CFTR in cystic fibrosis and cholera: From membrane transport to clinical practice

American Journal of Physiology - Advances in Physiology Education

Volumn 29, Issue 2, 2005, Pages 75-82

  Goodman, Barbara E ^a   Percy, William H ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Airway epithelia; Enterocyte; Mucus; Salty sweat

Indexed keywords

EID: 22344457654     PISSN: 10434046     EISSN: 15221229     Source Type: Journal    
DOI: 10.1152/advan.00035.2004     Document Type: Review

References (38)

1. Al-Awqati Q. Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors. J Clin Invest 110: 1599-1601, 2002.
2. Bradford WD. Atlas of Gastroenterology, edited by Yamada T, Alpers DH, Owang C, Powell D, Silverstien D, and Silverstien FE. Philadelphia, PA: Lippincott, 1992, Fig. 49-9.
3. Choi JY, Muallem D, Kiselyov K, Lee MG, Thomas PJ, and Muallem S. Aberrant CFTR-dependent HCO3 transport in mutations associated with cystic fibrosis. Nature 401: 94-97, 2001.
4. Coates, SW Jr, Hogenauer C, Santa Ana CA, Rosenblatt RL, Emmett M, and Fordtran JS. Inhibition of neutral sodium absorption by a prostaglandin analogue in patients with cystic fibrosis. Gastroenterology 127: 65-72, 2004.
5. Cuthbert AW, Halstead J, Ratcliff R, Colledge WH, and Evans MJ. The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J Physiol 482: 449-454, 1995.
6. Cystic Fibrosis Foundation. What is CF [Online]. http://www.cff.org/ about_cf [May 2003].
7. Da Cunha Ferreira RMC and Cash RA History of the development of oral rehydration therapy. Clin Ther, Suppl 12: 2-13, 1990.
8. Dasgupta B and King M. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase. Pediatr Pulmonol 22: 161-166, 1996.
9. - secretion by benzimidazolones. II. Coordinate regulation of apical GCl and basolateral GK. Am J Physiol Lung Cell Mol Physiol 271: L785-L795, 1996.
10. Duggan C, Fontaine O, Pierce NF, Glass RI, Mahalanabis D, Alam NH, Bhan MK, and Santosham M. Scientific rationale for a change in the composition of oral rehydration solution. JAMA 291: 2628-2635, 2004.
11. Field M, Rao MC, and Chang EB. Intestinal electrolyte transport and diarrheal disease. N Engl J Med 321: 879-883, 1989.
12. Gadsby DC and Nairn AC. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev 79, Suppl: S77-S107, 1999.
13. Gelman MS and Kopito RR. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. J Clin Invest 110: 1591-1597, 2002.
14. Glass RI, Libel M, and Brandling-Bennett AD. Epidemic cholera in the Americas. Science 256: 1524-1525, 1992.
15. Granger DN, Barrowman JA, and Kvietys PR. The small intestine. In: Clinical Gastrointestinal Physiology. Philadelphia, PA: Saunders, chapt. 7, 1985.
16. Griesenbach U, Ferrari S, Geddes DM, and Alton EWFW. Gene therapy progress and prospects: cystic fibrosis. Gene Ther 9: 1344-1350, 2002.
17. Hug MJ, Tamada T, and Bridges RJ. CFTR and bicarbonate secretion to epithelial cells. News Physiol Sci 18: 38-42, 2003.
18. Ji HL, Chalfant ML, Jovov B, Lockhart JP, Parker SB, Fuller CM, Stanton BA, and Benos DJ. The cytosolic termini of the β- and γ-ENaC subunits are involved in the functional interactions between cystic fibrosis transmembrane conductance regulator and epithelial sodium channel. J Biol Chem 275: 27947-27956, 2000.
19. Knowles MR, Clarke LL, and Boucher RC. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 325: 575-577, 1991.
20. Kunzelmann K. CFTR: interacting with everything?. News Physiol Sci 16: 167-170, 2001.
21. Lewis R. TIGR introduces Vibrio cholerae genome. Scientist 21: 8, 2000.
22. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJV, and Verkman AS. Thiazolidinone CFTR inhibitor identified by highthroughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658, 2002.
23. McElvaney NG, Doujaiji B, Moan MJ, Burnham MR, Wu MC, and Crystal RG. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am Rev Respir Dis 148: 1056-1060, 1993.
24. Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, Cohen MB, Calderwood SB, Schoolnik GK, and Camill A. Host-induced epidemic spread of the cholera bacterium. Nature 417: 642-645, 2002.
25. Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, Ratcliff R, Evans MJ, and Colledge WH. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393: 79-82, 1998.
26. Quinton PM. Physiological basis of cystic fibrosis: a historical perspective. Physiol Rev 79, Suppl: S3-S22, 1999.
27. Reddy MM and Quinton PM. Altered electrical potential profile of human reabsorptive sweat duct cells in cystic fibrosis. Am J Physiol Cell Physiol 257: C722-C726, 1989.
28. Schreiber R, Nitschke R, Greger R, and Kunzelmann K. The cystic fibrosis transmembrane conductance regulator activates aquaporin 3 in airway epithelial cells. J Biol Chem 274: 11811-11816, 1999.
29. Schroeder SA, Gaughan DM, and Swift M. Protection against bronchial asthma by CFTR ΔF508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med 1: 703-705, 1995.
30. Sheppard DN and Welsh MJ. Structure and function of CFTR chloride channel. Physiol Rev 79, Suppl: S23-S45, 1999.
31. Thiagarajah JR, Broadbent T, Hsieh E, and Verkman AS. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. Gastroenterology 126: 511-519, 2004.
32. Vasconcellos CA, Allen PG, Wohl ME, Drazen JM, Janmey PA, and Stossel TP. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263: 969-971, 1994.
33. Wagner JA and Gardner P. Toward cystic fibrosis gene therapy. Annu Rev Med 48: 203-216, 1997.
34. Weller PH. Implications of early inflammation and infection in cystic fibrosis: a review of new and potential interventions. Pediatr Pulmonol 24: 143-146, 1997.
35. Welsh MJ and Smith AE. Cystic fibrosis. Sci Am 273: 52-59, 1995.
36. Welsh MJ and Ramsey BW. Research on cystic fibrosis: a journey from the heart house. Am J Respir Crit Care Med 157: S148-S154, 1998.
37. World Health Organization. Cholera fact sheet [Online]. http://www.who.int/mediacentre/factsheets/fs107/en/ [March 2000].
38. World Health Organization. Weekly Epidemiological Record 76: 117-124, 2001.